ANTIOXIDANT ACTIVITY AND DFT STUDIES OF ETHYL 2-(2-((6-METHYL-4-OXO-4H-CHROMEN-3-YL) METHYLENE)HYDRAZINYL)THIAZOLE-4-CARBOXYLATE
DOI:
https://doi.org/10.24193/subbchem.2026.1.15Keywords:
microwave-assisted synthesis, antioxidant activity, DFT calculation, chromene, thiazoleAbstract
ABSTRACT. The microwave-assisted improved synthesis of ethyl 2-(2-((6-methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)thiazole-4-carboxylate is described. The antioxidant potential of the target compound was evaluated using spectrophotometric methods, including the DPPH• and ABTS•⁺ radical scavenging assays, as well as three additional electron-transfer assays employing metal-based oxidizing agents. The title compound exhibited good antioxidant activity compared to reference antioxidants. For the title compound theoretical quantum chemical (DFT) calculations were performed.
References
1. Chelliah, R.; Banan-MwineDaliri, E.; Oh, D.-H. Screening for Antioxidant Activity: Total Antioxidant Assay. In; 2022; pp. 459–460.
2. Theodosis-Nobelos, P.; Tziona, P.; Poptsis, A.; Athanasekou, C.; Kourounakis, P.N.; Rekka, E.A. Activity. Med. Chem. Res. 2017, 26, 461–472, doi:10.1007/s0044-016-1767-8.
3. K. Ahmouda and M. T. Oucif Khaled, Plant Physiol. Biochem., 2025, 222, 109723 doi: 10.1016/j.plaphy.2025.109723.
4. A. Grozav, I.-D. Porumb, L. Găină, L. Filip, and D. Hanganu, Molecules, 2017, 22(2), 260. doi: 10.3390/molecules22020260.
5. O. Sabin, R. M. Pop, I. C. Bocșan,V.S. Chedea, F. Ranga, A.Grozav, A. M. Levai, A. D. Buzoianu, Molecules, 2024, 29(15), 3448. doi: 10.3390/molecules29153448.
6. A. Grozav, L. I. Găină, V. Pileczki, O. Crisan, L. Silaghi-Dumitrescu, B. Therrien, V. Zaharia and I. Berindan-Neagoe. Int. J. Mol. Sci., 2014, 15(12), 22059–22072. doi: 10.3390/ijms151222059.
7. A. Grozav, V. Miclaus, O. Vostinaru, S. Ghibu, C. Berce, I. Rotar, C. Mogosan, B. Therrien, F. Loghin, D.-S. Popa. Regul. Toxicol. Pharmacol., 2016, 80, 233–240. doi: 10.1016/j.yrtph.2016.06.018.
8. A. Grozav, V. Zaharia, C. Cristea, N. I. Fit, Studia UBB Chemia, 2015, 60(3), 283-289.
9. G. Kumari, S. Dhillon, P. Rani, M. Chahal, D. K. Aneja, and M. Kinger, ACS Omega, 2024, 9(17), 18709–18746, doi: 10.1021/acsomega.3c10299.
10. S.S Shatokhin; V.A. Tuskaev; S.C. Gagieva; D.I. Pozdnyakov; E.T Oganesyan, Pharm. Pharmacol. 2021, 9, 367–376, doi:10.19163/2307-9266-2021-9-5-367-376.
11. S.P. Pawar, D.D. Kondhare, P.K. Zubaidha, Med. Chem. Res. 2013, 22, 753–757, doi:10.1007/s00044-012-0069-z.
12. E. Csepanyi, P. Szabados-Furjesi, A. Kiss-Szikszai, L.M. Frensemeier, U. Karst, I. Lekli, D.D. Haines, A. Tosaki, I. Bak, Molecules 2017, 22, 588, doi:10.3390/molecules22040588.
13. U. Salar, K. M. Khan, A. Jabeen, S. Hussain, A. Faheem, F. Naqvi and S. Perveen Lett. Drug Des. Discov., vol. 17, no. 5, pp. 547–555, May 2020, doi: 10.2174/1570180816666190611155218.
14. M. J. Saadh, Z. N.Jawad, S. M. Dhia Younis, W. K. Mohammed, M.K. Sultan, J. Rizaev, U. S. Altimari, M. J. Naser, M. L. Shaghnab, H. K. Shareef, I. Ahmad, A. Alawadi J. Mol. Struct., vol. 1338, p. 142093, Aug. 2025, doi: 10.1016/j.molstruc.2025.142093.
15. A. Grozav, C. Azarov, G. Marc, A. Pîrnău, S. Manolov, O. Oniga and O. Crișan, Molbank, vol. 2026, no. 1, p. M2127, Jan. 2026, doi: 10.3390/M2127.
16. G. Marc, A. Stana, M. Tertiş, C. Cristea, A. Ciorîţă, Ș.M. Drăgan, V. A. Toma, R. Borlan, M. Focșan, A. Pîrnău, L. Vlase, S. Oniga, O. Oniga, Int. J. Mol. Sci. 2023, 24, 13277, doi:10.3390/ijms241713277.
17. M. N. Alam, N.J. Bristi, M. Rafiquzzaman. Saudi Pharm. J. 2013, 21, 143–152, doi:10.1016/j.jsps.2012.05.002.
18. I. F. Benzie, J. J. Strain, Methods Enzymol. 1999, 299, 15–27, doi:10.1016/S0076-6879(99)99005-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Studia Universitatis Babeș-Bolyai Chemia

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
